J&J Covid-19 vaccine trial in SA: What early results on safety from the Sisonke study revealed - News Summed Up

J&J Covid-19 vaccine trial in SA: What early results on safety from the Sisonke study revealed


Healthcare workers received the vaccine as part of the the country's Sisonke Covid vaccine study. The other four cases of blood clots occurred in women aged 64, 45, 38, and 65. The safety data report highlights that the five cases of blood clots translates to 1.7 events per 100 000 participants. READ | What are the blood clots associated with the Johnson & Johnson Covid-19 vaccine? READ | Covid-19 vaccine blood clot condition can be fixed, German scientists believe


Source: News 24 June 04, 2021 02:48 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */